MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

H3B-6545

CAS No. : 2052130-80-8

MCE 站：H3B-6545

产品活性：H3B-6545 是一种有效的，具有口服活性的选择性雌激素受体共价拮抗剂 (SERCA)。H3B-6545 可用于研究转移性 ER 阳性，HER2 阴性乳腺癌。

研究领域：Others

作用靶点：Estrogen Receptor/ERR

In Vitro: H3B-6545 is a highly selective small molecule that potently antagonizes wild-type and mutant ERα in biochemical and cell based assays. In vitro comparisons with standard of care and other experimental agents confirm increased cell potency of H3B-6545 under continuous as well as washout treatment conditions. H3B-6545, a member of a novel class of ERα antagonists refer to as selective ER covalent antagonist (SERCA), which inactivates both wild-type and mutant ERα by targeting C530 and enforcing a unique antagonist conformation. H3B-6545 is a first-in-class selective ER covalent antagonist (SERCA). H3B-6545 inhibits ERα^WT activity and growth of ERα^WT -positive breast cancer lines. H3B-6545 potently inhibits ERα^WT activity and suppresses proliferation of ERα^WT -positive breast cancer lines. With GI₅₀s of 0.3-0.4, 1.0, 0.5, 5.2, and 0.2 nM for MCF7, HCC1428, BT483, T47D and CAMA-1 cell lines.

In Vivo: In vivo, once daily oral dosing of H3B-6545 shows potent activity and superior efficacy to fulvestrant in the MCF-7 xenograft model with maximal antitumor activity at doses >10x below the maximum tolerated dose in mice. In addition, H3B-6545 shows superior antitumor activity to Tamoxifen and Fulvestrant in patient derived xenograft models of estrogen receptor positive breast cancer including models carrying ERα mutations in rat and monkeys, H3B-6545 is well tolerated across a broad dose range and at exposures that significantly exceed those required for efficacy in mouse xenograft models.

相关产品：Covalent Screening Library Plus  |  Drug Repurposing Compound Library Plus  |  Clinical Compound Library Plus  |  Bioactive Compound Library Plus  |  Anti-Cancer Compound Library  |  Clinical Compound Library  |  Drug Repurposing Compound Library  |  Covalent Screening Library  |  Orally Active Compound Library  |  Anti-Breast Cancer Compound Library  |  Tamoxifen  |  Fulvestrant  |  Estradiol  |  4-Hydroxytamoxifen  |  Kaempferol  |  G15  |  G-1  |  Cholesterol  |  Bazedoxifene acetate  |  PHTPP  |  Raloxifene hydrochloride  |  DPN  |  Estrone  |  Chrysin  |  (-)-(S)-Equol  |  27-Hydroxycholesterol  |  Liquiritigenin  |  Propyl pyrazole triol  |  Toremifene citrate  |  Genistin  |  Diethylstilbestrol  |  Saikosaponin D  |  Lasofoxifene Tartrate  |  (20S)-Protopanaxatriol  |  Estriol  |  Prinaberel  |  Clomiphene citrate  |  Kaempferide

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。